<p> </p> <p>On Tuesday 13 October Instruct-ERIC are hosting a webinar in collaboration with Refeyn, to discuss Mass Photometry and how it can benefit your research.</p> <p> </p> <p style="text-align:…

<p> </p> <p>On Tuesday 13 October Instruct-ERIC are hosting a webinar in collaboration with Refeyn, to discuss Mass Photometry and how it can benefit your research.</p> <p> </p> <p style="text-align:…

<p> </p> <p>On Tuesday 13 October Instruct-ERIC are hosting a webinar in collaboration with Refeyn, to discuss Mass Photometry and how it can benefit your research.</p> <p> </p> <p style="text-align:…

<p> </p> <p>On Tuesday 13 October Instruct-ERIC are hosting a webinar in collaboration with Refeyn, to discuss Mass Photometry and how it can benefit your research.</p> <p> </p> <p style="text-align:…

<p> </p> <p>On Tuesday 13 October Instruct-ERIC are hosting a webinar in collaboration with Refeyn, to discuss Mass Photometry and how it can benefit your research.</p> <p> </p> <p style="text-align:…

<p> </p> <p>On Tuesday 13 October Instruct-ERIC are hosting a webinar in collaboration with Refeyn, to discuss Mass Photometry and how it can benefit your research.</p> <p> </p> <p style="text-align:…

## Riepilogo OggettoItalia – Attrezzature da laboratorio, ottiche e di precisione (escluso vetri) – PROCEDURA APERTA SOPRA SOGLIA COMUNITARIA PER L'AFFIDAMENTO DELLA FORNITURA DI UN REFEYN TWOMP MASS PHOTOMETER Stazione appaltanteCnr - I.b.p.m. TED IDb4b98cef-f58e-46a9-9fea-c80e7edc83f3 ### This post is for subscribers only Become a member to get access to all content Subscribe now

## Riepilogo OggettoItalia – Attrezzature da laboratorio, ottiche e di precisione (escluso vetri) – PROCEDURA APERTA SOPRA SOGLIA COMUNITARIA PER L'AFFIDAMENTO DELLA FORNITURA DI UN REFEYN TWOMP MASS PHOTOMETER Stazione appaltanteCnr - I.b.p.m. Scadenza12/05/2025 LuogoRoma, It TED IDf9260115-b191-4338-9ac8-c1e75b249a0c ### This post is for subscribers only Become a member to get access to all content Subscribe now

10:30 - 12:30h CET (Berlin time).

08:00 - 18:00h CET (Berlin time).

This article is sponsored by Refeyn. mRNA vaccines are easily programmable medicines that offer several advantages over traditional vaccines. By providing human cells with the blueprint for key antigen proteins, they can stimulate robust immune responses. While they became widely employed during the COVID-19 pandemic, researchers are now using mRNA vaccines to treat and help prevent a range of other diseases, including viral, parasitic, and bacterial infections, and cancers. In this article, explore how RNA vaccines work, how they were developed, and their advantages, applications, challenges, and emerging areas of research. RNA Vaccines: The Basics What is an RNA vaccine? RNA vaccines, or messenger RNA (mRNA) vaccines, are a relatively new type of vaccine that delivers mRNA molecules to human cells, instructing them to produce specific antigens.1 In the case of viral mRNA vaccines, the mRNA sequence is produced from a DNA template and typically encodes part of a protein found on the viral capsid. The mRNA is then encapsulated in a lipid nanoparticle (LNP). In this application, mRNA vaccines induce an immune response that primes the body to combat a future infection with the real target. There are two key types of RNA vaccines: Non-replicating synthetic mRNA vaccines and...

Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). To showcase this development, Refeyn has launched a new webpage that highlights how leading CROs and CDMOs are redefining process development and manufacturing workflows with mass photometry, and provides researchers with an interactive tool to locate and partner with these organizations.

Refeyn, the company behind pioneering mass photometry technology, has been named in The Sunday Times 100 Tech 2026, an annual ranking of the fastest-growing private technology companies in the UK. The Sunday Times 100 Tech list recognizes companies based on three-year revenue growth, highlighting businesses that have demonstrated sustained commercial momentum and technological impact. Refeyn ranked 39th in the hardware category, reflecting revenue growth of approximately 40% over the last three years. The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.

Bio-Techne and Refeyn have launched a groundbreaking workflow that revolutionizes the characterization of bispecific antibodies and biosimilars, ensuring faster and more efficient development processes.

Bio‑Techne (NASDAQ: TECH) and Refeyn launched an integrated workflow that links MauriceFlex™ icIEF fractionation with TwoMP mass photometry for bispecific antibody and biosimilar analysis.The four‑hour process directly correlates charge variants with size and aggregation using nanogram‑level samples, aiming to cut development risk and speed biosimilar manufacturing.

Jeho kariéru od počátku provází překážky. Vědec se přesto nenechal zlomit a proměnil svůj vynález v globální komerční úspěch.